lobbying_activities: 1954735

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1954735	f79fb37b-00c0-46e0-a9b7-7445ee594653	Q1	KASOWITZ LLP	401103221	SPECTRUM PHARMACEUTICALS	2017	first_quarter	MED	Regulation of the medical use of nuclear materials and its effect on cancer patient access.	HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),SENATE	25000		0	0	2017-04-17T16:01:05.947000-04:00